These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26345199)

  • 1. Long-term Multi-product Facial Regimen in Subjects with Moderate-to-severe Photodamage and Hyperpigmentation.
    Herndon JH; Makino ET; Jiang LI; Stephens TJ; Mehta RC
    J Clin Aesthet Dermatol; 2015 Aug; 8(8):16-21. PubMed ID: 26345199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of a novel multimodality hydroquinone-free skin brightener over six months.
    Bruce S
    J Drugs Dermatol; 2013 Mar; 12(3):S27-31. PubMed ID: 23545930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facial primer provides immediate and long-term improvements in mild-to-moderate facial hyperpigmentation and fine lines associated with photoaging.
    Roberts WE; Jiang LI; Herndon JH
    Clin Cosmet Investig Dermatol; 2015; 8():471-7. PubMed ID: 26366102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroquinone-free Skin Brightener System for the Treatment of Moderate-to-severe Facial Hyperpigmentation.
    Herndon JH; Makino ET; Stephens TJ; Mehta RC
    J Clin Aesthet Dermatol; 2014 May; 7(5):27-31. PubMed ID: 24847406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of In-Office Chemical Peels With a Topical Comprehensive Pigmentation Control Product in Skin of Color Subjects With Facial Hyperpigmentation.
    Downie J; Schneider K; Goberdhan L; Makino ET; Mehta RC
    J Drugs Dermatol; 2017 Apr; 16(4):301-306. PubMed ID: 28403262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brightening and Improvement of Facial Skin Quality in Healthy Female Subjects With Moderate Hyperpigmentation or Dark Spots and Moderate Facial Aging.
    Serra M; Bohnert K; Narda M; Granger C; Sadick N
    J Drugs Dermatol; 2018 Dec; 17(12):1310-1315. PubMed ID: 30586263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the safety and efficacy of topical copper chlorophyllin in women with photodamaged facial skin.
    Sigler ML; Stephens TJ
    J Drugs Dermatol; 2015 Apr; 14(4):401-4. PubMed ID: 25844615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Open Label Clinical Trial to Evaluate the Efficacy and Tolerance of a Retinol and Vitamin C Facial Regimen in Women With Mild-to-Moderate Hyperpigmentation and Photodamaged Facial Skin.
    Herndon JH; Jiang LI; Kononov T; Fox T
    J Drugs Dermatol; 2016 Apr; 15(4):476-82. PubMed ID: 27050703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging.
    Fabi SG; Goldman MP
    J Drugs Dermatol; 2013 Mar; 12(3):S32-7. PubMed ID: 23545931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
    Makino ET; Mehta RC; Garruto J; Gotz V; Sigler ML; Herndon JH
    J Drugs Dermatol; 2013 Mar; 12(3):s21-6. PubMed ID: 23545929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia.
    Wang J; Fabi S; Robinson D; Bajaj S; Geronemus R; Bell M; Widgerow A
    J Drugs Dermatol; 2023 Apr; 22(4):333-338. PubMed ID: 37026875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone.
    Makino ET; Herndon JH; Sigler ML; Gotz V; Garruto J; Mehta RC
    J Drugs Dermatol; 2012 Dec; 11(12):1478-82. PubMed ID: 23377519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Open Label Clinical Trial of a Multi-Ingredient Anti-Aging Moisturizer Designed to Improve the Appearance of Facial Skin.
    Herndon JH; Jiang L; Kononov T; Fox T
    J Drugs Dermatol; 2015 Jul; 14(7):699-704. PubMed ID: 26151786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-label study assessing the efficacy and tolerability of topical skincare and sun protection products following intense pulsed light treatment.
    Jones IT; Guiha I; Fabi SG
    J Cosmet Dermatol; 2018 Jun; 17(3):441-447. PubMed ID: 29164778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of a superficial chemical peel combined with a multimodal, hydroquinone-free skin brightener using in vivo reflectance confocal microscopy.
    Goberdhan LT; Mehta RC; Aguilar C; Makino ET; Colvan L
    J Drugs Dermatol; 2013 Mar; 12(3):S38-41. PubMed ID: 23545932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroquinone-free multimodal topical regimen for facial hyperpigmentation.
    Foad MS; Winters E
    J Drugs Dermatol; 2013 Mar; 12(3):S42-4. PubMed ID: 23545933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen.
    Fu JJ; Hillebrand GG; Raleigh P; Li J; Marmor MJ; Bertucci V; Grimes PE; Mandy SH; Perez MI; Weinkle SH; Kaczvinsky JR
    Br J Dermatol; 2010 Mar; 162(3):647-54. PubMed ID: 20374604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Trifecting
    Jiang L; Hino PD; Bhatia A; Stephens TJ; Jimenez F
    J Clin Aesthet Dermatol; 2018 Dec; 11(12):21-25. PubMed ID: 30666274
    [No Abstract]   [Full Text] [Related]  

  • 19. Extension Phase of a Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia.
    Wang JV; Fabi SG; Robinson DM; Bajaj S; Geronemus RG; Bell M; Robison T; Widgerow AD
    J Drugs Dermatol; 2024 Jan; 23(1):1266-1270. PubMed ID: 38206144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-Step Skincare Regimen Addressing Aging in Three Unique Geographic Locations: A Prospective, Multi-Center, Open-Label Study.
    Cohen J; Palm M; Biesman B; Young M; Kononov T; Zahr A
    J Drugs Dermatol; 2023 Jan; 22(1):16-22. PubMed ID: 36607762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.